- Home
- UTHR vs MAS Comparison
UTHR vs MAS Comparison
Compare UTHR & MAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- MAS
- Stock Information
- Founded
- UTHR 1996
- MAS 1929
- Country
- UTHR United States
- MAS United States
- Employees
- UTHR N/A
- MAS N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- MAS Industrial Specialties
- Sector
- UTHR Health Care
- MAS Industrials
- Exchange
- UTHR Nasdaq
- MAS Nasdaq
- Market Cap
- UTHR 14.4B
- MAS 14.2B
- IPO Year
- UTHR 1999
- MAS N/A
- Fundamental
- Price
- UTHR $297.02
- MAS $65.85
- Analyst Decision
- UTHR Buy
- MAS Buy
- Analyst Count
- UTHR 13
- MAS 13
- Target Price
- UTHR $383.08
- MAS $72.65
- AVG Volume (30 Days)
- UTHR 551.5K
- MAS 2.2M
- Earning Date
- UTHR 07-30-2025
- MAS 07-31-2025
- Dividend Yield
- UTHR N/A
- MAS 1.84%
- EPS Growth
- UTHR 18.86
- MAS N/A
- EPS
- UTHR 25.10
- MAS 3.66
- Revenue
- UTHR $2,994,100,000.00
- MAS $7,703,000,000.00
- Revenue This Year
- UTHR $14.30
- MAS N/A
- Revenue Next Year
- UTHR $6.32
- MAS $4.05
- P/E Ratio
- UTHR $11.79
- MAS $18.44
- Revenue Growth
- UTHR 19.84
- MAS N/A
- 52 Week Low
- UTHR $266.98
- MAS $56.55
- 52 Week High
- UTHR $417.82
- MAS $86.70
- Technical
- Relative Strength Index (RSI)
- UTHR 51.32
- MAS 54.70
- Support Level
- UTHR $286.68
- MAS $64.82
- Resistance Level
- UTHR $301.75
- MAS $68.49
- Average True Range (ATR)
- UTHR 6.73
- MAS 1.55
- MACD
- UTHR 1.81
- MAS 0.27
- Stochastic Oscillator
- UTHR 77.16
- MAS 65.82
About UTHR United Therapeutics Corporation
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.
About MAS Masco Corporation
Masco manufactures a variety of home improvement and building products. The company's $5-billion plumbing segment, led by the Delta and Hansgrohe brands, sells faucets, showerheads, and other related plumbing fixtures and components. The $3-billion decorative architectural segment primarily sells paints and other coatings under the Behr and Kilz brands, but it also sells builder hardware and lighting products.